Abstract
Bone marrow mesenchymal stem cells (MSCs) transplantation could repair injury tissue, but no study confirms whether MSCs can promote the proliferation of endogenous lung stem cells to repair alveolar epithelial cells of mice with chronic obstructive pulmonary disease (COPD). This study was designed to investigate the effect of MSCs on the proliferation of endogenous lung stem cells in COPD mice to confirm the repair mechanism of MSCs. The mice were divided into control group, COPD group, and COPD+MSCs group. The following indexes were detected: HE staining of lung tissue, the mean linear intercept (MLI) and alveolar destructive index (DI), the total cell number in bronchoalveolar lavage fluid (BALF), pulmonary function, alveolar wall apoptosis index (AI) and proliferation index (PI), the number of CD45-/CD31-/Sca-1+ cells by flow cytometry (FCM), and the number of bronchoalveolar stem cells (BASCs) in bronchoalveolar duct junction (BADJ) by immunofluorescence. As compared with control group, the number of inflammatory cells in lung tissue was increased, alveolar septa was destroyed and the emphysema-like changes were seen, and the changes of lung function were in line with COPD in COPD group; AI of alveolar wall was significantly increased and PI significantly decreased in COPD group. There was no significant difference in the number of CD45-/CD31-/Sca-1+ cells and BASCs between control group and COPD group. As compared with COPD group, the number of inflammatory cells in BALF was decreased, the number of CD45-/CD31-/Sca-1+ cells and BASCs was increased, AI of alveolar wall was decreased and PI was increased, and emphysema-like changes were relieved in COPD+MSCs group. These findings suggested that MSCs transplantation can relieve lung injury by promoting proliferation of endogenous lung stem cells in the cigarette smoke-induced COPD mice.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Vestbo J, Hurd SS, Agusti AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med, 2013,187(4):347–365
Quanjer PH. Correctly defining criteria for diagnosing chronic obstructive pulmonary disease matters. Am J Respir Crit Care Med, 2014,189(2):230
Culver B. Defining airflow limitation and chronic obstructive pulmonary disease: the role of outcome studies. Eur Respir J, 2015,46(1):8–10
Hawkins PE, Alam J, McDonnell TJ, et al. Defining exacerbations in chronic obstructive pulmonary disease. Expert Rev Respir Med, 2015,9(3):277–286
Aaron SD. Management and prevention of exacerbations of COPD. BMJ, 2014,349:g5237
Goodwin M, Sueblinvong V, Eisenhauer P, et al. Bone marrow-derived mesenchymal stromal cells inhibit Th2-mediated allergic airways inflammation in mice. Stem Cells, 2011,29(7):1137–1148
O’Reilly M, Thebaud B. Cell-based strategies to reconstitute lung function in infants with severe bronchopulmonary dysplasia. Clin Perinatol, 2012,39(3): 703–725
Matthay MA, Thompson BT, Read EJ, et al. Therapeutic potential of mesenchymal stem cells for severe acute lung injury. Chest, 2010,138(4):965–972
Lee JW, Krasnodembskaya A, McKenna DH, et al. Therapeutic effects of human mesenchymal stem cells in ex vivo human lungs injured with live bacteria. Am J Respir Crit Care Med, 2013,187(7):751–760
Weiss DJ. Concise review: current status of stem cells and regenerative medicine in lung biology and diseases. Stem Cells, 2014,32(1):16–25
Rock JR, Hogan BL. Epithelial progenitor cells in lung development, maintenance, repair, and disease. Annu Rev Cell Dev Biol, 2011,27:493–512
McQualter JL, Bertoncello I. Concise review: Deconstructing the lung to reveal its regenerative potential. Stem Cells, 2012,30(5):811–816
Weiss DJ. Stem cells, cell therapies, and bioengineering in lung biology and diseases. Comprehensive review of the recent literature 2010-2012. Ann Am Thorac Soc, 2013,10(5):S45–97
Hatzistergos KE, Quevedo H, Oskouei BN, et al. Bone marrow mesenchymal stem cells stimulate cardiac stem cell proliferation and differentiation. Circ Res, 2010,107(7):913–922
Tropea KA, Leder E, Aslam M, et al. Bronchioalveolar stem cells increase after mesenchymal stromal cell treatment in a mouse model of bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol, 2012,302(9):L829–837
Jin Z, Pan X, Zhou K, et al. Biological effects and mechanisms of action of mesenchymal stem cell therapy in chronic obstructive pulmonary disease. J Int Med Res, 2015,43(3):303–310
Kumar PA, Hu Y, Yamamoto Y, et al. Distal airway stem cells yield alveoli in vitro and during lung regeneration following H1N1 influenza infection. Cell, 2011,147(3): 525–538
Nolen-Walston RD, Kim CF, Mazan MR, et al. Cellular kinetics and modeling of bronchioalveolar stem cell response during lung regeneration. Am J Physiol Lung Cell Mol Physiol, 2008,294(6):L1158–1165
Kim CF, Jackson EL, Woolfenden AE, et al. Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell, 2005,121(6):823–835
Zhen G, Liu H, Gu N, et al. Mesenchymal stem cells transplantation protects against rat pulmonary emphysema. Front Biosci, 2008,13:3415–3422
Adenuga D, Yao H, March TH, et al. Histone deacetylase 2 is phosphorylated, ubiquitinated, and degraded by cigarette smoke. Am J Respir Cell Mol Biol, 2009,40(4): 464–473
Huh JW, Kim SY, Lee JH, et al. Bone marrow cells repair cigarette smoke-induced emphysema in rats. Am J Physiol Lung Cell Mol Physiol, 2011,301(3):L255–266
Chen Y, Hanaoka M, Chen P, et al. Protective effect of beraprost sodium, a stable prostacyclin analog, in the development of cigarette smoke extract-induced emphysema. Am J Physiol Lung Cell Mol Physiol, 2009,296(4):L648–656
Kajstura J, Rota M, Hall SR, et al. Evidence for human lung stem cells. N Engl J Med, 2011,364(19):1795–1806
Chilosi M, Poletti V, Rossi A. The pathogenesis of COPD and IPF: distinct horns of the same devil? Respir Res, 2012,13:3
Crystal RG, Randell SH, Engelhardt JF, et al. Airway epithelial cells: current concepts and challenges. Proc Am Thorac Soc, 2008,5(7):772–777
Tzouvelekis A, Laurent G, Bouros D. Stem cell therapy in chronic obstructive pulmonary disease. Seeking the Prometheus effect. Curr Drug Targets, 2013,14(2):246–252
Author information
Authors and Affiliations
Corresponding author
Additional information
This project was supported by a program of Medical Research of Henan Province (No. 102300410247).
Rights and permissions
About this article
Cite this article
Liu, Hm., Ma, Lj., Wu, Jz. et al. MSCs relieve lung injury of COPD mice through promoting proliferation of endogenous lung stem cells. J. Huazhong Univ. Sci. Technol. [Med. Sci.] 35, 828–833 (2015). https://doi.org/10.1007/s11596-015-1514-2
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11596-015-1514-2